greeksoup/ stock research

Eastman Chemical Co.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 30 July 2026: press release. Guidance figures: 1 lowered, 1 new, 2 kept. The quarter’s numbers.

Key takeaways

  • Q2 sequential sales jumped 15 percent: Sales revenue increased to $2,513 million in Q2 from $2,177 million in Q1, driven by 8 percent higher sales volume and mix plus 7 percent higher selling prices sequentially across the company. Source
  • Adjusted EBIT margin expanded 350 basis points: Adjusted EBIT margin improved to 12.7 percent in Q2 from 9.2 percent in Q1, driven by volume and mix improvement, price-cost management in specialties, and spread expansion in Chemical Intermediates. Source
  • Adjusted EPS grew 81 percent sequentially: Adjusted earnings per diluted share reached $1.97 in Q2 versus $1.09 in Q1, up 23 percent year-over-year from $1.60 in Q2 2025, reflecting strong operational execution. Source
  • Chemical Intermediates revenue surged 39 percent: Chemical Intermediates sales jumped to $643 million from $463 million year-over-year on 24 percent higher volume and 14 percent higher prices, driven by olefin and derivative products benefiting from Middle East supply disruptions. Source
  • Volume and mix contributed 5 percent growth: Sales volume and mix accounted for 5 percent of 10 percent year-over-year growth, with Advanced Materials up 4 percent, Chemical Intermediates up 24 percent, and Fibers down 10 percent. Source
  • Kingsport methanolysis facility building momentum: Kingsport facility continues commercial ramp-up with strategic momentum as key contributor to innovation-driven growth, expected to be primary driver of specialty growth for full year 2026. Source
  • Operating cash flow guidance reduced to $900 million: Company lowered full-year operating cash flow expectation to approach $900 million from prior guidance of approaching 2025 levels, attributed to inflationary pressure on accounts receivable. Source

“We also delivered strong spread expansion and volume/mix improvement in Chemical Intermediates. These actions resulted in a 350-basis-point sequential increase in our EBIT margin.”

Mark Costa, Board Chair and CEO

Guidance

AreaPeriodFigureAgainst last quarter
Operating cash flow Sourcefull year 2026approach $900 millionLowered from approaching 2025 levels
Cost reduction savings Sourcefull year 2026$125 million to $150 million, net of inflationKept
Capital expenditures Sourcefull year 2026approximately $400 millionKept
Third-quarter adjusted EPS Sourcethird quarter 2026approach $1.97New

What changed from last quarter

  • Guidance lowered: Operating cash flow guidance reduced to approach $900 million from prior expectation of approaching 2025 levels, attributed to inflationary pressure on accounts receivable. Source
  • New guidance: Company initiated specific third-quarter 2026 adjusted EPS guidance to approach $1.97, projecting flat sequential performance from Q2. Source

Sequential growth and margin expansion

  • Q2 sequential sales jumped 15 percent: Sales revenue increased to $2,513 million in Q2 from $2,177 million in Q1, driven by 8 percent higher sales volume and mix plus 7 percent higher selling prices sequentially across the company. Source
  • Adjusted EBIT margin expanded 350 basis points: Adjusted EBIT margin improved to 12.7 percent in Q2 from 9.2 percent in Q1, driven by volume and mix improvement, price-cost management in specialties, and spread expansion in Chemical Intermediates. Source
  • Adjusted EPS grew 81 percent sequentially: Adjusted earnings per diluted share reached $1.97 in Q2 versus $1.09 in Q1, up 23 percent year-over-year from $1.60 in Q2 2025, reflecting strong operational execution. Source

Segment performance and dynamics

  • Chemical Intermediates revenue surged 39 percent: Chemical Intermediates sales jumped to $643 million from $463 million year-over-year on 24 percent higher volume and 14 percent higher prices, driven by olefin and derivative products benefiting from Middle East supply disruptions. Source
  • Fibers contracted 11 percent on inventory destocking: Fibers sales fell to $243 million from $274 million year-over-year as 10 percent lower volume from customer acetate tow destocking and weak textiles offset modest 8 percent sequential volume recovery. Source
  • Additives & Functional Products maintained stability: Additives sales increased 5 percent on 4 percent higher prices from cost-pass-through contracts, with adjusted EBIT unchanged as improved price-cost offset higher planned maintenance expense. Source

“Our team has demonstrated agility in the first half and is focused on building on the momentum and solid results delivered in the first half of 2026, despite the constantly changing impact of the Middle East conflict and continued weak demand in key discretionary end markets.”

Mark Costa, Board Chair and CEO

Price-cost execution and volume

  • Volume and mix contributed 5 percent growth: Sales volume and mix accounted for 5 percent of 10 percent year-over-year growth, with Advanced Materials up 4 percent, Chemical Intermediates up 24 percent, and Fibers down 10 percent. Source
  • Second-half pricing momentum expected to continue: Management expects modest tailwind from specialty price increases in second half of 2026 as increases continue offsetting raw material and distribution cost pressures through year-end. Source

Cost reduction and operational execution

  • Cost reduction initiatives delivering substantial progress: Company reported substantial progress toward $125 million to $150 million cost savings target net of inflation, with benefits evident through favorable currency rates and operational improvements across segments. Source
  • Supply chain reliability maintained amid disruptions: Company leveraged integrated U.S.-based assets to maintain supply reliability for customers amid Middle East conflict, securing key raw materials and managing logistics to support customer operations. Source

“we remain confident we can significantly improve earnings in 2026 versus 2025”

Mark Costa, Board Chair and CEO

Strategic initiatives and circular growth

  • Kingsport methanolysis facility building momentum: Kingsport facility continues commercial ramp-up with strategic momentum as key contributor to innovation-driven growth, expected to be primary driver of specialty growth for full year 2026. Source
  • Circular platform doubled first-half revenue: Circular product platform achieved doubled revenue in first half of 2026 compared to prior year with continued operational performance supporting strategic momentum building. Source
  • Capital-efficient packaging market options advancing: Company made substantial progress on capital-efficient set of options to serve packaging market, indicating disciplined approach to growth while maintaining capital efficiency standards. Source

Cash flow and capital allocation

  • Operating cash flow guidance reduced to $900 million: Company lowered full-year operating cash flow expectation to approach $900 million from prior guidance of approaching 2025 levels, attributed to inflationary pressure on accounts receivable. Source
  • Working capital expected to release in H2: Management expects to release working capital in second half of 2026, helping offset inflationary pressure on accounts receivable from elevated costs. Source
  • Capital priorities unchanged with balance sheet discipline: Company maintains quarterly dividend payments, disciplined capital expenditures of approximately $400 million, and opportunistic share repurchases while preserving investment-grade balance sheet. Source

Coming up, as management said on 30 July 2026

  • Kingsport facility commercial ramp-up continuing: Company will continue commercial ramp-up of Kingsport methanolysis facility, expecting it to be primary driver of specialty growth through innovation-driven growth model in 2026. Source
  • Q3 adjusted EPS expected to approach $1.97: Third-quarter 2026 adjusted EPS projected to approach Q2 level of $1.97 based on improved Advanced Materials pricing and utilization, higher Fibers volume, seasonal Additives decline, and moderating Chemical Intermediates spreads. Source
  • Second-half working capital release expected: Management expects to release working capital in second half of 2026 to support operating cash flow toward full-year target of approaching $900 million. Source
  • Cost reduction delivery through second half: Company remains on track to deliver full $125 million to $150 million of cost savings net of inflation through remainder of 2026. Source

Risks management discussed

  • External: Middle East conflict duration and impact remain uncertain, with potential to dampen consumer demand despite current favorable effect on Chemical Intermediates margins and supply availability.
  • Demand: Weak demand in consumer discretionary end markets continues, with textiles market weakness and automotive expected to decline low-single-digits limiting specialty segment growth. Source
  • Operational: Customer inventory destocking in acetate tow continues to reduce Fibers volume and profitability, though expected to moderate as customers meet annual contracts in Q3. Source
  • Financial: Inflationary environment creating pressure on accounts receivable and working capital, narrowing pathway to achieve historical cash flow levels and requiring H2 working capital release. Source
  • Operational: Elevated logistics costs from Middle East conflict serve customers and manage supply chains, pressuring Fibers segment profitability. Source

Earlier plans management reported on

  • On track: Management reported substantial progress toward cost reduction goal and remains committed to full-year delivery of stated savings target. Source
  • On track: Company maintaining disciplined capital spending commitment of approximately $400 million for full year 2026. Source
  • On track: Management reported continued solid progress on commercial ramp-up with operational and financial goals for facility on track.
  • On track: Management remains confident in ability to significantly improve full-year 2026 earnings relative to 2025 based on current momentum, innovation growth, and cost initiatives. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.